University Students' Vaccination Intention after the Fifth Wave of the COVID-19 Outbreak in Hong Kong: Inspiration from a Health Belief Model
- PMID: 38921318
- PMCID: PMC11203942
- DOI: 10.3390/healthcare12121204
University Students' Vaccination Intention after the Fifth Wave of the COVID-19 Outbreak in Hong Kong: Inspiration from a Health Belief Model
Abstract
The fifth wave of COVID-19, driven by the Omicron variant, started to surge in Hong Kong in December 2021. Previous studies have shown that younger adults, compared to older adults, are vulnerable to increased risks of side effects after vaccination. However, little is known about the COVID-19 vaccination behavior among younger adults, especially university students, in Hong Kong. Therefore, the present online survey study aimed to investigate the predictors of COVID-19 vaccination intention among university students in Hong Kong using the Health Belief Model (HBM) as a framework. Two other potential predictors, the previous influenza vaccine uptake frequency and the Hong Kong SAR government vaccination lottery program, were also examined. The intention to receive another dose of the COVID-19 vaccine was low (36.4%). Multivariate binomial logistic regression analysis showed that, after controlling for demographic and baseline characteristics, the perceived susceptibility (OR = 2.98, CI = 1.18-7.53) and previous influenza vaccine uptake frequency (OR = 1.54, CI = 1.08-2.19) significantly and positively predicted the COVID-19 vaccination intention. However, the government vaccination lottery program (i.e., wining prizes for being vaccinated) (OR = 0.87, CI = 0.34-2.26) was not a significant motivator of COVID-19 vaccination. Future public health campaigns should focus on the individual susceptibility to COVID-19 and past influenza vaccination history to promote increased vaccination uptake among university students.
Keywords: COVID-19 vaccination intention; Health Belief Model; government vaccination lottery program; influenza vaccine uptake; university students.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Living in a Region With a Low Level of COVID-19 Infection: Health Belief Toward COVID-19 Vaccination and Intention to Receive a COVID-19 Vaccine in Hong Kong Individuals.Inquiry. 2022 Jan-Dec;59:469580221082787. doi: 10.1177/00469580221082787. Inquiry. 2022. PMID: 35352982 Free PMC article.
-
Why do Hong Kong parents have low intention to vaccinate their children against COVID-19? testing health belief model and theory of planned behavior in a large-scale survey.Vaccine. 2022 Apr 26;40(19):2772-2780. doi: 10.1016/j.vaccine.2022.03.040. Epub 2022 Mar 21. Vaccine. 2022. PMID: 35339306 Free PMC article.
-
Predictors of Intention to Vaccinate against COVID-19 in the General Public in Hong Kong: Findings from a Population-Based, Cross-Sectional Survey.Vaccines (Basel). 2021 Jun 25;9(7):696. doi: 10.3390/vaccines9070696. Vaccines (Basel). 2021. PMID: 34202016 Free PMC article.
-
Intention to receive COVID-19 vaccine and its health belief model (HBM)-based predictors: A systematic review and meta-analysis.Hum Vaccin Immunother. 2023 Dec 31;19(1):2207442. doi: 10.1080/21645515.2023.2207442. Epub 2023 May 12. Hum Vaccin Immunother. 2023. PMID: 37170620 Free PMC article.
-
Updated consensus statements on COVID-19 Vaccine Allergy Safety in Hong Kong.Asia Pac Allergy. 2022 Jan 24;12(1):e8. doi: 10.5415/apallergy.2022.12.e8. eCollection 2022 Jan. Asia Pac Allergy. 2022. PMID: 35174059 Free PMC article. Review.
References
-
- Chatterjee S., Bhattacharya M., Nag S., Dhama K., Chakraborty C. A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies. Viruses. 2023;15:167. doi: 10.3390/v15010167. - DOI - PMC - PubMed
-
- Cheng S.M.S., Mok C.K.P., Leung Y.W.Y., Ng S.S., Chan K.C.K., Ko F.W., Chen C., Yiu K., Lam B.H.S., Lau E.H.Y., et al. Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination. Nat. Med. 2022;28:486–489. doi: 10.1038/s41591-022-01704-7. - DOI - PMC - PubMed
-
- Khandia R., Singhal S., Alqahtani T., Kamal M.A., El-Shall N.A., Nainu F., Desingu P.A., Dhama K. Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environ. Res. 2022;209:112816. doi: 10.1016/j.envres.2022.112816. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous